Correction to: Cenobamate: real-world data from a retrospective multicenter study.

This correction notice is for an article titled "Cenobamate: real-world data from a retrospective multicenter study" published in the Journal of Neurology. The original article contained an incorrect abstract. The study analyzed the efficacy and safety of cenobamate (CNB), an anti-seizure medication, in a large real-world cohort of patients with various epilepsy syndromes. The primary outcome was treatment response, and secondary outcomes included seizure freedom rates, adverse drug reactions, and changes in concomitant anti-seizure medications. The study found that CNB was highly effective and generally well-tolerated in patients with drug-resistant epilepsy. [Extracted from the article]